Intracellular uptake of EGCG-loaded deformable controlled release liposomes for skin cancer

References

• Alexander, A., et al., 2012. Approaches for breaking the barriers of drug permeation through transdermal drug delivery. Journal of control release, 164 (1), 26–40.
   PubMed Web of Science ®Google Scholar
• Ali, M.H., et al., 2013. The role of lipid geometry in designing liposomes for the solubilisation of poorly water soluble drugs. International journal of pharmaceutics, 453 (1), 225–232. doi: 10.1016/j.ijpharm.2012.06.056.
   PubMed Web of Science ®Google Scholar
• Ali, S.M., et al., 2007. Poor adherence to treatments: a fundamental principle of dermatology. Archives of dermatology, 143 (7), 912–915.
   PubMedGoogle Scholar
• Almog, S., et al., 1986. Kinetic and structural aspects of reconstitution of phosphatidylcholine vesicles by dilution of phosphatidylcholine-sodium cholate mixed micelles. Biochemistry, 25 (9), 2597–2605.
   PubMed Web of Science ®Google Scholar
• American Cancer Society, 2017. Cancer Facts and Figures. http://www.cancer.org/acs/groups/content/@editorial/documents/document/acspc-048738.pdf. Accessed 10/01/2017.
   Google Scholar
• Bae, J.Y., et al., 2008. (-)Epigallocatechin gallate hampers collagen destruction and collagenase activation in ultraviolet-B-irradiated human dermal fibroblasts: involvement of mitogen-activated protein kinase. Food and chemical toxicology: an international journal published for the British industrial biological research association, 46 (4), 1298–1307.
   PubMed Web of Science ®Google Scholar
• Bangham, A.D., Standish, M.M., and Watkins, J.C., 1965. Diffusion of univalent ions across the lamellae of swollen phospholipids. Journal of molecular biology, 13 (1), 238–252.
   PubMed Web of Science ®Google Scholar
• Bansal, T., et al., 2009. Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. Journal of pharmacy & pharmaceutical sciences, 12 (1), 46–78.
   PubMed Web of Science ®Google Scholar
• Basnet, P., et al., 2012. Liposomal delivery system enhances anti-inflammatory properties of curcumin. Journal of pharmaceutical sciences, 101 (2), 598–609.
   PubMed Web of Science ®Google Scholar
• Bernfield, M., et al., 1999. Functions of cell surface heparan sulfate proteoglycans. Annual review of biochemistry, 68 (1), 729–777.
   PubMed Web of Science ®Google Scholar
• Bouwstra, J.A. and Honeywell-Nguyen, P.L., 2002. Skin structure and mode of action of vesicles. Advanced drug delivery reviews, 54(Suppl 1), S41–S55.
   PubMed Web of Science ®Google Scholar
• Bradfield, A. and Penney, M., 1948. The catechins of green tea. Part II. Journal of the chemical society (Resumed), 456, 2249–2254.
   Google Scholar
• Calpena, A., et al., 1994. A comparative in vitro study of transdermal absorption of antiemetics. Journal of pharmaceutical sciences, 83 (1), 29–33.
   PubMed Web of Science ®Google Scholar
• Carey, M.P. and Burish, T.G., 1988. Etiology and treatment of the psychological side effects associated with cancer chemotherapy: a critical review and discussion. Psychological bulletin, 104 (3), 307.
   PubMed Web of Science ®Google Scholar
• Casas, M. and Baszkin, A., 1992. Interactions of a non-ionic surfactant with mixed phospholipid—oleic acid monolayers. Surface potential and surface pressure studies at constant area. Colloid surface, 63 (3–4), 301–309.
   Web of Science ®Google Scholar
• Casey, S.C., et al., 2015. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in cancer biology, 35, S199–223
   Web of Science ®Google Scholar
• Cevc, G., 1995. Material transport across permeability barriers by means of lipid vesicles. Handbook of biological physics, 1, 465–490.
   Google Scholar
• Cevc, G., 1996. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Critical reviews™ in therapeutic drug carrier systems, 13 (3–4), 257–388.
   PubMed Web of Science ®Google Scholar
• Cevc, G., et al., 1993. Ultra-high efficiency of drugs and peptide transfer through the intact skin by means of novel drug carriers, transfersomes. Cardiff, UK: STS Publishing.
   Google Scholar
• Cevc, G., et al., 1998. Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochimica et biophysica acta (BBA) – biomembranes, 1368 (2), 201–215.
   PubMed Web of Science ®Google Scholar
• Cevc, G; Schätzlein, A.; Gebauer, D.; Blume, G., 1993. Ultra-high efficiency of drug and peptide transfer through the intact skin by means of novel drug-carriers, Transfersomes. In: Bain KRH J., James, W.J.; Water, K.A., eds. Prediction of percutaneous penetration. Cardiff: STS Publishing, 226–234.
   Google Scholar
• Chen, C.-C., et al., 2010. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. European journal of pharmaceutics and biopharmaceutics, 74 (3), 474–482.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2012. Preparation of curcumin-loaded liposomes and evaluation of their skin permeation and pharmacodynamics. Molecules, 17 (5), 5972–5987.
   PubMed Web of Science ®Google Scholar
• Chen, Z.P., et al., 1998. Green tea epigallocatechin gallate shows a pronounced growth inhibitory effect on cancerous cells but not on their normal counterparts. Cancer letters, 129 (2), 173–179.
   PubMed Web of Science ®Google Scholar
• Cho, H.H., et al., 2008. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-ε-caprolactone) as stent-coating materials. Biomaterials, 29 (7), 884–893.
   PubMed Web of Science ®Google Scholar
• Chu, K.A. and Yalkowsky, S.H., 2009. An interesting relationship between drug absorption and melting point. International journal of pharmaceutics, 373 (1–2), 24–40.
   PubMed Web of Science ®Google Scholar
• Chung, H. and Caffrey, M., 1994. The curvature elastic-energy function of the lipid-water cubic mesophase. Nature, 368 (6468), 224–226.
   PubMed Web of Science ®Google Scholar
• Dick, I.P. and Scott, R.C., 1992. Pig ear skin as an in-vitro model for human skin permeability. The journal of pharmacy and pharmacology, 44 (8), 640–645.
   PubMed Web of Science ®Google Scholar
• Diepgen, T.L. and Mahler, V., 2002. The epidemiology of skin cancer. The British journal of dermatology, 146 (Suppl 61), 1–6.
   PubMed Web of Science ®Google Scholar
• Donaldson, M.R. and Coldiron, B.M., editors, 2011. No end in sight: the skin cancer epidemic continues. Seminars in cutaneous medicine and surgery. Frontline Medical Communications, 30 (1) 3–5.
   Google Scholar
• du Plessis, J., Weiner, N., and Müller, D., 1994. The influence of in vivo treatment of skin with liposomes on the topical absorption of a hydrophilic and a hydrophobic drug in vitro. International journal of pharmaceutics, 103 (2), R1–R5.
   Web of Science ®Google Scholar
• El Zaafarany, G.M., et al., 2010. Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. International journal of pharmaceutics, 397 (1–2), 164–172.
   PubMed Web of Science ®Google Scholar
• El Maghraby, G.M., Barry, B.W., and Williams, A.C., 2008. Liposomes and skin: from drug delivery to model membranes. European journal of pharmaceutical sciences, 34 (4–5), 203–222.
   PubMed Web of Science ®Google Scholar
• El Maghraby, G.M.M., Williams, A.C., and Barry, B.W., 2000. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. International journal of pharmaceutics, 196 (1), 63–74.
   PubMed Web of Science ®Google Scholar
• El, M., WA, C., and BB, W., 2001. Skin delivery of 5-fluorouracil from ultradeformable and standard liposomes in-vitro. Journal of pharmacy and pharmacology, 53 (8), 1069–1077. doi:
   PubMed Web of Science ®Google Scholar
• Felicio, L., et al., 2009. Long-term follow-up of topical 5-aminolaevulinic acid photodynamic therapy diode laser single session for non-melanoma skin cancer. Photodiagnosis and photodynamic therapy, 6, 207–213.
   PubMed Web of Science ®Google Scholar
• Fresta, M. and Puglisi, G., 1996. Application of liposomes as potential cutaneous drug delivery systems. In vitro and in vivo investigation with radioactively labelled vesicles. Journal of drug targeting, 4 (2), 95–101.
   PubMed Web of Science ®Google Scholar
• Godin, B. and Touitou, E., 2007. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. Advanced drug delivery reviews, 59 (11), 1152–1161.
   PubMed Web of Science ®Google Scholar
• Goindi, S., et al., 2013. Development of novel elastic vesicle-based topical formulation of cetirizine dihydrochloride for treatment of atopic dermatitis. Aaps Pharmscitech, 14 (4), 1284–1293.
   PubMed Web of Science ®Google Scholar
• Gompper, G. and Kroll, D.M., 1995. Driven transport of fluid vesicles through narrow pores. Physical review. E, statistical physics, plasmas, fluids, and related interdisciplinary topics, 52 (4), 4198–4208.
   PubMed Web of Science ®Google Scholar
• Gupta, S., et al., 2004. Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene, 23 (14), 2507–2522.
   PubMed Web of Science ®Google Scholar
• Guy, R.H. and Hadgraft, J., 1985. Transdermal drug delivery: a simplified pharmacokinetic approach.International journal of pharmaceutics, 24 (2–3), 267–274.
   Web of Science ®Google Scholar
• Hiruta, Y., et al., 2006. Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. Journal of control release, 113 (2), 146–154.
   PubMed Web of Science ®Google Scholar
• Huang, C.-C., et al., 2005. Protective effects of (-)-epicatechin-3-gallate on UVA-induced damage in HaCaT keratinocytes. Archives of dermatological research, 296 (10), 473–481.
   PubMed Web of Science ®Google Scholar
• Huang, C.-C., et al., 2007. (-)-Epicatechin-3-gallate, a green tea polyphenol is a potent agent against UVB-induced damage in HaCaT keratinocytes. Molecules, 12 (8), 1845–1858.
   PubMed Web of Science ®Google Scholar
• Hwang, J.-T., et al., 2007. Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer letters, 247 (1), 115–121.
   PubMed Web of Science ®Google Scholar
• Ita, K.B., et al., 2007. Dermal delivery of selected hydrophilic drugs from elastic liposomes: effect of phospholipid formulation and surfactants. Journal of pharmacy and pharmacology, 59 (9), 1215–1222.
   PubMed Web of Science ®Google Scholar
• Ito, A., et al., 2007. 4-S-Cysteaminylphenol-loaded magnetite cationic liposomes for combination therapy of hyperthermia with chemotherapy against malignant melanoma. Cancer science, 98 (3), 424–430.
   PubMed Web of Science ®Google Scholar
• Kanadaswami, C., et al., 2005. The antitumor activities of flavonoids. In vivo (Athens, Greece), 19 (5), 895–909.
   PubMed Web of Science ®Google Scholar
• Kang, S.N., et al., 2013. Enhancement of liposomal stability and cellular drug uptake by incorporating tributyrin into celecoxib-loaded liposomes. Asian journal of pharmaceutical sciences, 8 (2), 128–133.
   Google Scholar
• Kaplan, B. and Moy, R.L., 2000. Effect of perilesional injections of PEG-interleukin-2 on basal cell carcinoma. Dermatologic surgery: official publication for American society for dermatologic surgery [et al.], 26 (11), 1037–1040.
   PubMed Web of Science ®Google Scholar
• Karande, P. and Mitragotri, S., 2009. Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochimica et biophysica acta (BBA) —biomembranes, 1788 (11), 2362–2373.
   PubMed Web of Science ®Google Scholar
• Kirjavainen, M., et al., 1996. Interaction of liposomes with human skin in vitro—the influence of lipid composition and structure. Biochimica et biophysica acta (BBA)—Lipids and lipid metabolism, 1304 (3), 179–189.
   PubMed Web of Science ®Google Scholar
• Korsmeyer, R.W., et al., 1983. Mechanisms of solute release from porous hydrophilic polymers. International journal of pharmaceutics, 15 (1), 25–35.
   Web of Science ®Google Scholar
• Kyung, O.Y., et al., 2009. Toxicity of amorphous silica nanoparticles in mouse keratinocytes. Journal of nanoparticle research, 11 (1), 15–24.
   Web of Science ®Google Scholar
• Lasic, D. D. and Barenholz, Y., 1996. Handbook of nonmedical applications of liposomes: theory and basic sciences. London: CRC Press.
   Google Scholar
• Lentz, B.R., Carpenter, T.J., and Alford, D.R., 1987. Spontaneous fusion of phosphatidylcholine small unilamellar vesicles in the fluid phase. Biochemistry, 26 (17), 5389–5397.
   PubMed Web of Science ®Google Scholar
• Levy, M.Y., Benita, S., and Baszkin, A., 1991. Interactions of a non-ionic surfactant with mixed phospholipid—oleic acid monolayers. Studies under dynamic conditions. Colloid surface, 59, 225–241.
   Web of Science ®Google Scholar
• Lomas, A., Leonardi-Bee, J., and Bath-Hextall, F., 2012. A systematic review of worldwide incidence of nonmelanoma skin cancer. British journal of dermatology, 166 (5), 1069–1080.
   PubMed Web of Science ®Google Scholar
• Lopez, R.F., et al., 2011. Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate. Biomaterials, 32 (3), 933–941.
   PubMed Web of Science ®Google Scholar
• Martin, F.J. and MacDonald, R.C., 1976. Lipid vesicle-cell interactions. I. Hemagglutination and hemolysis. The journal of cell biology, 70 (3), 494–505.
   PubMed Web of Science ®Google Scholar
• McLoughlin, P., et al., 2004. Transcriptional responses to epigallocatechin-3 gallate in HT 29 colon carcinoma spheroids. Genes to cells, 9 (7), 661–669.
   PubMed Web of Science ®Google Scholar
• Mislick, K.A. and Baldeschwieler, J.D., 1996. Evidence for the role of proteoglycans in cation-mediated gene transfer. Proceedings of the national academy of sciences of the *United States of America, 93 (22), 12349–12354.
   PubMed Web of Science ®Google Scholar
• Neslihan Gursoy, R. and Benita, S., 2004. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & pharmacotherapy, 58 (3), 173–182.
   PubMed Web of Science ®Google Scholar
• Neville, J.A., Welch, E., and Leffell, D.J., 2007. Management of nonmelanoma skin cancer in 2007. Nature clinical practice. Oncology, 4 (8), 462–469.
   PubMedGoogle Scholar
• Nishiyama, N., 2007. Nanomedicine: nanocarriers shape up for long life. Nature nanotechnology, 2 (4), 203–204.
   PubMed Web of Science ®Google Scholar
• Oh, Y.K., et al., 2006. Skin permeation of retinol in Tween 20-based deformable liposomes: in-vitro evaluation in human skin and keratinocyte models. Journal of pharmacy and pharmacology, 58 (2), 161–166.
   PubMed Web of Science ®Google Scholar
• Pagano, R.E. and Weinstein, J.N., 1978. Interactions of liposomes with mammalian cells. Annual review of biophysics and bioengineering, 7 (1), 435–468.
   PubMedGoogle Scholar
• Panyam, J. and Labhasetwar, V., 2003. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Advanced drug delivery reviews, 55 (3), 329–347.
   PubMed Web of Science ®Google Scholar
• Park, S.-I., et al., 2013. Polymer-hybridized liposomes of poly(amino acid) derivatives as transepidermal carriers. Colloids and surfaces. B, biointerfaces, 110, 333–338.
   PubMed Web of Science ®Google Scholar
• Patil, S., et al., 2007. Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials, 28 (31), 4600–4607.
   PubMed Web of Science ®Google Scholar
• Peppas, N.A. and Sahlin, J.J., 1989. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. International journal of pharmaceutics, 57 (2), 169–172.
   Web of Science ®Google Scholar
• Prausnitz, M.R. and Langer, R., 2008. Transdermal drug delivery. Nature biotechnology, 26 (11), 1261–1268.
   PubMed Web of Science ®Google Scholar
• Products EAftEoM. 2000. Note for guidance on the investigation of bioavailability and bioequivalence. London: European Agency for the Evaluation of Medicinal Products.
   Google Scholar
• Romero, E.L. and Morilla, M.J., 2013. Highly deformable and highly fluid vesicles as potential drug delivery systems: theoretical and practical considerations. International journal of nanomedicine, 8, 3171–3186.
   PubMed Web of Science ®Google Scholar
• Schäfer-Korting, M., Mehnert, W., and Korting, H.-C., 2007. Lipid nanoparticles for improved topical application of drugs for skin diseases. Advanced drug delivery reviews, 59 (6), 427–443.
   PubMed Web of Science ®Google Scholar
• Schmook, F.P., Meingassner, J.G., and Billich, A., 2001. Comparison of human skin or epidermis models with human and animal skin in in-vitro percutaneous absorption. International journal of pharmaceutics, 215 (1–2), 51–56.
   PubMed Web of Science ®Google Scholar
• Scudiero, D.A., et al., 1988. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer research, 48 (17), 4827–4833.
   PubMed Web of Science ®Google Scholar
• Seras, M., et al., 1992. Kinetic aspects of the solubilization of non-ionic monoalkyl amphiphile-cholesterol vesicles by octylglucoside. Chemistry and physics of lipids, 63 (1–2), 1–14.
   Web of Science ®Google Scholar
• Siddiqui, I.A., et al., 2009. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer research, 69 (5), 1712–1716.
   PubMed Web of Science ®Google Scholar
• Sigler, K. and Ruch, R.J., 1993. Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea. Cancer letters, 69 (1), 15–19.
   PubMed Web of Science ®Google Scholar
• Singh, B.N., Shankar, S., and Srivastava, R.K., 2011a. Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochemical pharmacology, 82 (12), 1807–1821.
   PubMed Web of Science ®Google Scholar
• Singh, T., et al., 2011b. Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E(2) and prostaglandin E(2) receptors. Carcinogenesis, 32 (1), 86–92.
   PubMed Web of Science ®Google Scholar
• Song, Y.-K. and Kim, C.-K., 2006. Topical delivery of low-molecular-weight heparin with surface-charged flexible liposomes. Biomaterials, 27 (2), 271–280.
   PubMed Web of Science ®Google Scholar
• Tanigawa, T., et al., 2014. (+)-Catechin protects dermal fibroblasts against oxidative stress-induced apoptosis. BMC complementary and alternative medicine, 14 (133).
   PubMed Web of Science ®Google Scholar
• Thawonsuwan, J., et al., 2010. Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss. Fish physiology and biochemistry, 36 (3), 687–697.
   PubMed Web of Science ®Google Scholar
• Trotta, M., et al., 2002. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. International journal of pharmaceutics, 241 (2), 319–327.
   PubMed Web of Science ®Google Scholar
• Trotta, M., et al., 2004. Deformable liposomes for dermal administration of methotrexate. International journal of pharmaceutics, 270 (1–2), 119–125.
   PubMed Web of Science ®Google Scholar
• Tsai, M.J., et al., 2015. Preparation and characterization of naringenin-loaded elastic liposomes for topical application. PLoS one, 10 (7), e0131026.
   PubMed Web of Science ®Google Scholar
• Vajjha, R.S., Das, D.K., and Kulkarni, D.P., 2010. Development of new correlations for convective heat transfer and friction factor in turbulent regime for nanofluids. International journal of heat and mass transfer, 53 (21–22), 4607–4618.
   Web of Science ®Google Scholar
• Vasconcelos, T., Sarmento, B., and Costa, P., 2007. Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug discovery today, 12 (23–24), 1068–1075.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2016. Enhanced solubility and bioavailability of naringenin via liposomal nanoformulation: preparation and in vitro and in vivo evaluations. Aaps Pharmscitech 18 (3), 586–594.
   Web of Science ®Google Scholar
• Weigmann, H., et al., 1999. Determination of the horny layer profile by tape stripping in combination with optical spectroscopy in the visible range as a prerequisite to quantify percutaneous absorption. Skin pharmacology and physiology, 12 (1–2), 34–45.
   Web of Science ®Google Scholar
• Weiner, N., Egbaria, K., and Ramachandran, C., 1992. Topical delivery of liposomally encapsulated interferon evaluated by in vitro diffusion studies and in a cutaneous herpes guinea pig model. In: O. Braun-Falco, H.C. Korting, H.I. Maibach, eds. Liposome dermatics: Griesbach Conference. Berlin, Heidelberg: Springer Berlin Heidelberg, 242–250.
   Google Scholar
• White, P.J., et al., 1999. Oligonucleotide uptake in cultured keratinocytes: influence of confluence, cationic liposomes, and keratinocyte cell type. Journal of investigative dermatology, 112 (5), 699–705.
   PubMed Web of Science ®Google Scholar
• World Health Organisation., 2017. Ultraviolet radiation (UV): Skin cancers. http://www.who.int/uv/faq/skincancer/en/index1.html [Accessed 20 November 2017].
   Google Scholar
• Yang, C.S., Maliakal, P., and Meng, X., 2002. Inhibition of carcinogenesis by tea. Annual review of pharmacology and toxicology, 42 (1), 25–54.
   PubMed Web of Science ®Google Scholar
• Zhao, Y.-Z., et al., 2013. Selection of high efficient transdermal lipid vesicle for curcumin skin delivery. International journal of pharmaceutics, 454 (1), 302–309.
   PubMed Web of Science ®Google Scholar